IXEMPRA® Kit (ixabepilone) for Injection, for intravenous infusion only. Initial
U.S. ... ixabepilone concentration in constituted solution is 2 mg/mL. Constituted ...
On October 16, 2007, the U.S. Food and Drug Administration (FDA) approved
ixabepilone for injection (Ixempra™, made by Bristol-Myers Squibb) for the ...
Ixabepilone is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug.
Ixabepilone is classified as an "antimicrotubule agent" or an "epothilone B ...
Pharmacokinetic studies with ixabepilone given on a daily dosing schedule have
demonstrated a rapid 1-log decline after drug infusion, later followed by a ...
Medscape - Indication-specific dosing for Ixempra (ixabepilone), frequency-
based adverse effects, comprehensive interactions, contraindications, pregnancy
Ixempra (ixabepilone): For the treatment of breast cancer. New approved drug
details including side effects, uses and general information.
Jul 10, 2010 ... Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus
Capecitabine in Patients With Metastatic Breast Cancer Previously ...
Nov 11, 2015 ... Brand name: Ixempra. Chemical name: Ixabepilone. Class: Epothilone
chemotherapy. No other epothilones are used to treat breast cancer.
IXEMPRA Kit (ixabepilone) for Injection, for intravenous infusion only. Initial U.S.
... DILUENT. The ixabepilone concentration in constituted solution is 2 mg/mL.
Easy to read patient leaflet for ixabepilone. Includes indications, proper use,
special instructions, precautions, and possible side effects.